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Abstract
It is well known that renal and neurological complications may occur after antifilarial treatment of
patients infected with Loa loa. Conversely, spontaneous cases of visceral complications of loiasis
have been rarely reported. A 31-year-old Congolese male patient who had not received any
antifilarial drug developed oedema of the lower limbs, and then transient swellings of upper limbs.
Two months after, he developed troubles of consciousness within several hours. At hospital, the
patient was comatose with mild signs of localization. Laboratory tests and an abdominal echography
revealed a chronic renal failure due to a glomerulopathy. Three weeks after admission, Loa
microfilariae were found in the cerebrospinal fluid, and a calibrated blood smear revealed a Loa
microfilaraemia of 74,200 microfilariae per ml. The level of consciousness of the patient improved
spontaneously, without any specific treatment, but several days after becoming completely lucid,
the patient died suddenly, from an undetermined cause. Unfortunately, no biopsy or autopsy could
be performed. The role of Loa loa in the development of the renal and neurological troubles of this
patient is questionable. But the fact that such troubles, which are known complications of Loa
infection, were found concomitantly in a person harbouring a very high microfilarial load suggests
that they might have been caused by the filarial parasite. In areas endemic for loiasis, examinations
for a Loa infection should be systematically performed in patients presenting an encephalopathy or
a glomerulopathy.
Findings
If the classical signs of loiasis (itching, eye worm and Cal-
abar swellings) are well known [1,2], the more serious
manifestations of the infection, i.e. the visceral ones, are
still poorly documented. The renal or the neurological
complications which have been reported by various
authors, often occurred after an antifilarial treatment with
diethylcarbamazine (DEC) or ivermectin [3-6]. In con-
trast, the descriptions of spontaneous complications are
fairly rare and, in such cases, their relationship with the
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sometimes questionable.
Various neurological manifestations, without any associ-
ated trouble of consciousness, have been attributed to loi-
asis: headaches, asthenia, somnolence, motor deficits,
troubles of sensation, and cerebellar, vestibular, or psychi-
atric disorders [7]. But, to our knowledge, the only cases
in which real troubles of consciousness occurred in
patients infected with Loa loa and who had possibly, prob-
ably or certainly not received any filaricidal treatment are
those reported by Bonnet, [8], Kivits, [9], Gallais et al.,
[10] and then Carayon et al., [11], Cauchie et al., [12],
Same-Ekobo et al., [13], and Negesse et al., [14]. The
patient described by Bonnet, [8] had certainly not taken
DEC or ivermectin because the first use of these antifilarial
drugs in humans took place in 1947 and 1980, respec-
tively. In the cases described by Cauchie et al., [12] and
Same-Ekobo et al., [13], a history of treatment before the
appearance of the troubles is fairly unlikely, because a
careful interview of the relatives had been performed. The
situation is probably the same for the patient described by
Gallais et al., [10], who was a Chadian soldier posted in
Indochina. Conversely, it is quite possible that one or sev-
eral of the patients described by Kivits, [9] had taken DEC
within the days preceding their hospitalization. Indeed, as
noticed by Fain, [15], DEC was already fairly widely avail-
able in the Mayumbe area (Bas-Congo province, Demo-
cratic Republic of the Congo, DRC) as soon as 1949–1950
and, as the neurological complications of DEC were not
known at that time, the author has naturally not asked the
question to the relatives of whether the patients had
received the drug or not. Besides this, the patient
described by Negesse et al., [14] had taken a "native med-
icine", and the authors raised the hypothesis that the latter
might have contained DEC. Thus, it appears that the spon-
taneous cases of Loa loa encephalopathy are exceptional.
Concerning the renal manifestations, long ago a number
of authors have reported the presence of an albuminuria,
and sometimes of a microscopic haematuria, in some
patients infected with Loa loa [16,17]. In several cases, a
renal biopsy had been performed before the administra-
tion of the antifilarial treatment, and the lesions observed
corresponded to glomerulopathies of various types [18-
22]. However, here again, the detailed observations are
fairly rare.
In this context, it seemed interesting to us to present in
detail the following case of a patient who was heavily
infected with Loa loa and who presented, successively, a
glomerulopathy and an encephalopathy.
Mr BL, 31 years old, was a Congolese (DRC) male who
was born in Kinshasa and who lived since 1998 in
Muanda (Bas-Congo Province). On the 11th of October,
2004, he was brought by his family to the General provin-
cial Hospital of Kinshasa because he showed troubles of
consciousness that had started on the previous day. Before
mid-2004, the patient had no special medical history,
except haemorrhoids. In July 2004, he complained of
abdominal pains, which were more important in the pel-
vic region, and accompanied by diarrhoea. He treated
himself with the traditional plants he took usually to treat
his haemorrhoids. This was followed by an improvement
in his diarrhoea but some time later the patient noticed
the appearance of oedema of both lower limbs and he
complained of a slight distending of abdomen. He treated
the oedemas by local applications of a paste made of a
mixture of plants. The oedemas diminished a little, but
the patient then noticed the appearance of transient swell-
ings of both upper limbs, accompanied with itching, that
he treated with promethazine oral syrup during one week.
The itching disappeared but the persistence of the oedema
of the lower limbs one month after their appearance
prompted the patient to go to Kinshasa so as to receive an
appropriate treatment. On the 20th of September, he went
to a health centre and, in addition to the oedema, a fever
was noticed by the nurse. A blood smear was prepared,
which showed a light infection with Plasmodium (noted as
+ on the laboratory register), and a treatment with oral
quinine and paracetamol was given. By the 8th of October,
the patient showed a fever in the evening during two days.
This was then accompanied with an oliguria, the appear-
ance of an oedema of the face on waking, and an asthenia.
In the morning of the 11th, the patient presented a func-
tional impairment and troubles of consciousness which
prompted his family to bring him to the General provin-
cial Hospital of Kinshasa (GHK).
At admission to the GHK, on the 11th of October (Hospi-
tal Day 1, HD1), the patient presented with confusion, a
swelling of the face, and a pitting oedema of the lower
limbs. The temperature was not measured but the patient
had a mild fever to the touch. The abdomen was soft, and
no organomegaly was found. The blood pressure was
110/80 mmHg and the respiratory frequency, 20 breaths/
min. There was no neck stiffness, the palpebral conjuncti-
vae were normal, and bronchial breath sounds were
found at auscultation. The rest of the examination was
normal. The results of the laboratory tests performed the
same day were as follows: low haematocrit, at 28% (nor-
mal value: 42–54%); leukocytosis at 12,000/mm3 (nor-
mal: 4000–10,000/mm3); normal glycemia at 0.98 g/l;
presence of Plasmodia in the thick blood smear (1 to 10
parasites per microscope field); albuminuria +++ on dip-
stick urine analysis; absence of glycosuria; and presence,
in the urine, of red blood cells (10/field) and of leuko-
cytes (10/field; normal value:< 5/field). A diagnosis of
nephrotic syndrome associated with a severe malaria wasPage 2 of 7
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cefotaxime, and quinine, was started. A permanent urine
catheter was put in place, in order to measure diuresis.
Additional biological examinations, and an abdominal
echography were prescribed.
On HD2 and HD3, the patient was in stage I coma, i.e.
responded to pain by more or less comprehensible words.
After an episode of agitation during the night of the HD2,
he was calm, and still subfebrile to the touch. The rest of
the condition was similar to the one recorded at admis-
sion. On HD3, the sedimentation rate was high, at 120
mm per hour; the leukocyte count had become normal at
4800/mm3; and a new blood smear still showed the pres-
ence of Plasmodium, but at a very low density (1 parasite
per 100 fields). On the HD4, an echography was per-
formed, whose results were as follows: "kidneys of normal
size and morphology, but with a marked loss of the cor-
tico-medullar differentiation, making them almost white;
liver increased in volume, but normal in its morphology
and homogeneous in its structure; presence of an ascites,
principally pelvic". It was concluded that the images were
strongly suggestive of a bilateral glomerulopathy, associ-
ated with an hepatomegaly which was probably reactional
to the renal disease. On HD5, the patient, whose clinical
condition was stable, was transfered to the Cliniques Uni-
versitaires de Kinshasa (CUK) for more extensive investiga-
tions.
On admission to the Emergency Unit of the CUK, the
patient was in stage II coma (i.e. he responded to pain by
no or incomprehensible sounds, but by an appropriate
motor response), without neck stiffness. He still presented
a swelling of the face, with an important oedema of the
eyelids which obstructed completely his left eye. The
oedema of the lower limbs was still present, the abdomen
was slightly distended, and a moderate ascites was found.
The temperature was 37.7°C, the blood pressure was 130/
90 mmHg, and the respiratory frequency was 20/min. The
results of the blood tests done on HD5 were as follows:
marked anemia, with an haemoglobin concentration of
7.5 g/100 ml (normalvalues: 13–17); haematocrit still
lower than at HD1, at 22%; normal leukocyte count, at
6800/mm3, with 79% neutrophils, 18% lymphocytes,
and 3% eosinophils; urea: 1.05 g/l(normal: 0.10–0.42);
creatinine: 29 mg/l(normal: 5–20); creatinine clearance:
27.6 ml/min(normal: > 60 ml/mn); glycemia: 1.13 g/l;
sodium concentration: 138 mEq/l; potassium: 4.6 mEq/l.
These results showed that the patient presented a marked
chronic renal failure, with albuminuria and haematuria
which, together with the echographic findings, suggested
that it was due to a glomerulopathy. The hypothesis is
raised that the renal failure might have been provoked by
a possible nephrotoxicity of the traditional plants taken
by the patient. Besides this, owing to the biological
results, the degree of the troubles of consciousness and the
clinical condition in general did not suggest an uraemic
coma. The treatment implemented at the GHK, which
included intravenous furosemide, cefotaxime and quinine
was continued. A renal biopsy was prescribed, but later
was not performed because of financial considerations.
On HD6, the hypothesis was raised, that the neurological
troubles would be due to a bacterial encephalitis or to a
severe malaria. A new blood smear was prepared, in which
no Plasmodium was found. On HD7, the calcemia was
measured; it was at 4.6 mEq/l, i.e. close to the lower limit
of normal (4.5–5.5); the bicarbonates were at 24 mmol/l
(normal: 18 to 33). On HD8, a complete clinical exami-
nation was done again. Besides the troubles of conscious-
ness, the oedema of the face and of the lower limbs, and
the absence of renal bruit at auscultation, the examination
showed several neurological signs which had not been
noticed previously: a left facial paralysis, a convergent
strabism of the right eye, an hypotonia of the right hemi-
body, a bilateral Babinski sign, and normal tendon
reflexes. The hypothesis was raised that the neurological
troubles might have been caused by an expansive intracra-
nial process, including a cerebral abcess possibly related
to an HIV infection. The patient was transfered to the
Intensive Care Unit of the CUK.
When he was admitted to the unit, on HD8, the patient
was still in a stage II coma, without fever nor meningeal
signs; the blood pressure was 120/80 mmHg, and the res-
piratory frequency, 24/min. The liver function tests per-
formed the same day were normal (conjugated bilirubin:
9 mg/l; unconjugated bilirubin: 3 mg/l; ALAT: 3 UI/l;
ASAT: 16 UI/l). A lumbar puncture was also performed
and the cerebrospinal fluid (CSF) obtained was crystal
clear, and showed no evidence of infection either at direct
microcopic examination or after culture. A fundus exami-
nation showed narrowed retinal arteries, perivenous
haemorrhages, several cotton-wool exudates, a slight mac-
ular oedema in the left eye, and well coloured and well
limited papillae. On HD9, the neurological condition was
stable, whereas the oedema of the lower limbs seemed to
have regressed a little. New blood tests showed that the
sedimentation rate was still high (150 mm per hour), an
increase in the haemoglobin concentration (8.9 g/100
ml), a calcemia at 4.2 mEq/l and bicarbonates at 20
mmol/l. The results of the CSF tests were as follows: red
blood cells: 79/mm3; leukocytes: 2/mm3; glucose: 0.68 g/
l; proteins: 0.64 g/l (normal: 0.20–0.40); chloride: 126
mmol/l (normal: 120–130 mmol/l). The association of a
high concentration of proteins with a low density of leu-
kocytes was characteristic of an albumino-cytologic disso-
ciation. A nasogastric tube was set up, in order to feed the
patient with 400–600 ml of gruel and 300–400 ml of
water per day, following the diuresis measured daily.Page 3 of 7
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with, in addition, a neck stiffness and an abolition of the
tendon reflexes. The sedimentation rate was 124 mm per
hour. As the possible intracranial process could be due to
an abscess caused by pyrogens, the ongoing treatment
with cefatoxime and quinine was completed by metroni-
dazole. On HD11, the glycemia was at 1.47 g/l. On HD13,
the hypothesis was raised that the neurological troubles
might be due to a thrombo-embolic complication of the
nephrotic syndrome. A cerebral CT scan was prescribed,
but was not performed. Quinine treatment was stopped.
On HD15, the patient who had remained apyretic until
then, showed a fever at 38.6°C; the temperature became
normal again two days after. On HD17, the leukocyte
count was 7900/mm3, with 70% neutrophils, 20% lym-
phocytes and 10% eosinophils. On HD18, the treatment
with metronidazole was interrupted, and though it was
most unlikely that the condition would be related to
stroke, a treatment by piracetam and multivitamins was
started, whereas cefatoxime was continued. In spite of the
continuing nursing care since the start of hospitalization,
bedsores on the trochanters appeared on HD19. The
patient was still in stage II coma. Bedsores on the coccyx
apperared on HD23. On HD24, the urine protein excre-
tion, quantified for the first time, was 1.30 g/24 h (nor-
mal: < 150 mg/24 h). On the same day, the blood pressure
was found to be elevated on several instances, with diasto-
lic values reaching or exceeding 100 mmHg. On HD25,
the Glasgow coma score was 7/15 (eye opening: 4/4;
motor response: 1/6; verbal response: 2/5). On the same
day, a new lumbar puncture was performed, and the CSF
was examined after double centrifugation to detect
trypanosomes. No trypanosome was found, but three Loa
loa microfilariae were counted. The other results concern-
ing the CSF were as follows: glucose: 0.97 g/l; proteins:
0.98 g/l; chloride: 130 mEq/l; red blood cells: 2560/mm3;
leukocytes: 4/mm3; absence of infection at direct exami-
nation and after culture; China ink stain to detect Crypto-
coccus neoformans capsules negative. Though the result on
the red blood cells might mean that the CSF was contam-
inated with blood, and thus microfilariae, from a vessel
injured during the tap, the presence of these Loa loa micro-
filariae suggested that the renal and neurological condi-
tions of the patient might correspond to complications of
a Loa loa infection. The same day, an HIV serology was
done, which was found negative.
The treatment by piracetam and vitamins was continued,
and a treatment by enalapril maleate (Envas) and
nadroparine calcium (Fraxiparine) was started to stabilize
the blood pressure and prevent thromboembolic compli-
cations due to prolonged bed rest, respectively. Two
options were considered to treat the Loa loa infection:
diethylcarbamazine (DEC) associated with corticoster-
oids, and a treatment with Vofil – a speciality made of
medicinal plants, manufactured and marketed in DRC –
in association with astemisol, an antihistaminic. These
treatments not being available, they were not adminis-
tered to the patient. On HD27, the patient's clinical con-
dition improved: he was in stage I coma. On HD28, the
appearance of a productive cough prompted the medical
team to start a treatment with carbocysteine syrup, which
was replaced by acetylcysteine on HD30. On HD29, the
haematocrit was 23% and the haemoglobin concentra-
tion was 8.2 g/100 ml. Treatment with nadroparine cal-
cium was stopped, and replaced with aspirin at low dose.
The clinical condition remained stable until HD34, when
the patient was found lucid and coherent, to our great sur-
prise. The nasogastric feeding tube was removed. During
the following days, the patient was asthenic and appeared
to be slightly out of touch with the reality, but he
responded to verbal command and his level of conscious-
ness improved progressively. He still showed mild pitting
oedema of the lower limbs. A calibrated (50 µl) blood
smear was prepared on HD35, and showed a high infec-
tion with Loa loa microfilariae (74,200 microfilariae per
ml of blood). This result, and the favourable evolution of
the condition, led to the project of treating the patient
with DEC being abandoned. At that time, the patient was
treated with piracetam per os, enalapril maleate, aspirin,
multivitamins, and nursing care for his bedsores. We con-
sidered the possibility, as soon as the patient's condition
would be satisfactory, of starting a long-term treatment
with albendazole in order to decrease his Loa microfilarae-
mia progressively. On HD39, the patient left the Intensive
Care Unit. His state of consciousness permitted question-
ing him in detail about the development of his troubles.
He clearly stated that he was well aware that a mass iver-
mectin treatment had been organized in some areas of the
Bas-Congo province in the first months of 2004, but that
for his part he did not take this treatment nor any other
antifilarial drug. On HD45, during nursing care for his
bedsores, the patient presented convulsions, and died
suddenly.
The relationships between the different troubles that the
patient has developed, in a sequential manner, within
three months between July and October 2004, cannot be
fully ascertained. The fact that he presented a very high Loa
loa microfilarial load constitutes one of the crucial ele-
ments of the picture. Owing to the prolonged effect of
DEC and ivermectin on the Loa microfilaraemia, [23], this
high load strongly suggests that the patient, as he
informed us when he could be questioned, had probably
not received any antifilarial treatment within the last
months, or even years. It is also noteworthy that the
oedema of the lower limbs had appeared shortly before
the appearance of signs that were suggestive of loiasis.Page 4 of 7
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by the patient was the oedema of his lower limbs. The lab-
oratory tests performed within the first days of hospitali-
zation demontrated a significant decrease in the
creatinine clearance, and thus showed that the troubles
were related to a renal failure. In addition, the echo-
graphic findings, and the presence of an important albu-
minuria associated with a microscopic haematuria led
rapidly to a diagnosis of glomerulopathy. As no renal
biopsy could be performed, it is difficult to determine the
exact type of renal lesions, or their aetiology. However, the
clinical and biological examinations that were performed
allow us to exclude several aetiologies: diabetic nephrop-
athy, HIV-associated nephropathy, gout nephropathy.
Besides this, a number of authors have reported cases of
patients who presented, as ours, an infection with Loa loa
and a renal disease with oedema of the lower limbs [20-
22].
In the present case, the troubles of consciousness
appeared fairly rapidly, within only several hours, after a
period of two days during which the patient had pre-
sented an evening fever and headaches. The presence of a
Plasmodium infection could explain the fever and possibly
the neurological symptoms; and this prompted us to start
treatment with quinine. However, the absence of
improvement during the following days strongly suggests
that the troubles were not due to a severe malaria. The fact
that the development of the coma was preceded by head-
aches, and the presence of mild signs of localization led us
to consider the possibility of an intracranial expansive
process. However, the absence of arterial hypertension, of
any signs of intracranial hypertension in the fundus, or of
any clinical improvement within the days following
implementation of a wide-spectrum antibiotherapy, as
well as the "spontaneous" subsequent improvement in
his clinical condition, finally led us to consider this possi-
bility as unlikely. The finding of Loa loa microfilariae in
the CSF, as well as the very high Loa microfilaraemia, con-
situte arguments in favour of a diagnosis of Loa encepha-
lopathy. In addition, the haemorrhages and cotton-wool
exudates found in the retina of our patient were similar to
those reported both in patients who developed a Loa
encephalopathy after ivermectin treatment [24], and in
individuals without history of antifilarial treatment but
harbouring a very high Loa microfilaraemia [25]. How-
ever, one should notice that the CSF contained also a
fairly high number of red blood cells, and thus that it
could have been contaminated by blood and microfilariae
coming from a vessel injured during the puncture.
In the absence of histological results, it is difficult to
affirm that the renal and neurological troubles developed
by our patient were indeed caused by his high Loa loa
infection. An improvement after an antifilarial treatment
would have constituted a strong argument in favour of
this possibility. But due to his very high microfilaraemia,
such a treatment would have probably induced, in our
patient who was still very weak, a serious adverse reaction
that would have led to a new aggravation of the picture.
We thus prefered to postpone the antifilarial treatment,
which finally could not be administered because of the
sudden and expected outcome. At the end, the main argu-
ment that makes us think that the renal and neurological
troubles might have been caused by Loa loa is the fact that
they are both known complications of Loa infection, and
that they occurred concomitantly in a patient harbouring
a very high microfilaraemia.
The pathogenic mechanisms associated with the Loa-
related serious adverse reactions after an antifilarial treat-
ment are imperfectly documented. As far as ivermectin is
concerned, it is probable that the drug provokes a fairly
rapid paralysis of the microfilariae, and that the latter,
floating passively in the blood circulation, may finally
provoke embolisms in the capillaries, especially in the
brain [24]. In addition, it has been shown that ivermectin
provokes a passage of the blood Loa loa microfilariae into
the CSF and into the urine [4]. These phenomena might
explain the neurological and renal complications that
occur sometimes after treatment. In contrast, the factors
associated with a spontaneous development of a Loa-
related encephalopathy or glomerulopathy are unknown.
Several authors have raised the hypothesis that an inter-
current or a concomitant affection weakening the blood-
brain barrier might provoke lesions at the vascular level
and/or facilitate the passage of the microfilariae into the
brain tissue. This could be the case with trypanosomiasis
[8,26], syphilis [8], an acute encephalitis [9], an infection
associated with flu symptoms [12,27], or a local suppura-
tion [9]. The possible role of malaria should also be con-
sidered. Indeed, when admitted to hospital, our patient
was also infected with Plasmodium, as was one of the cases
reported by Kivits, [9]. Besides this, the child whose his-
tory was described by Same Ekobo et al., [13] had pre-
sented, three days before the appearance of the
neurological troubles, "a fever eliminated by quinine
treatment". As Plasmodium infection is also very frequent
in those areas endemic for Loa loa, these observations may
be purely coincidental. However, the possible role of Plas-
modium as a cofactor facilitating the development of a
post-ivermectin Loa encephalopathy has also been raised
[6], and a study is ongoing in Cameroon to investigate
this point. Lastly, one may imagine that a cranial trauma-
tism could also provoke capillary lesions that would facil-
itate the passage of the microfilariae into the cerebral
parenchyma; this could explain the clinical picture
described by Gallais et al., [10] in a soldier who "had
received a blow with a butt on his head".Page 5 of 7
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was probably the rapid improvement in the neurological
condition, within only several days. As pointed out above,
the interval between the start of quinine treatment and
this improvement is too long for malaria being the cause
of the condition. On the other hand, the clinical changes
we have observed were similar to those described by
Cauchie et al., [12] in a patient who had developed a Loa
encephalopathy that was probably spontaneous. In the
latter case, "the troubles of consciousness lasted five days,
and then disappeared completely, without any specific
treatment" (the patient died subsequently, when the diag-
nosis of loiasis was made, and after several days of treat-
ment with DEC and corticosteroid, that provoked a coma
that was, this time, fatal). It seems that, even in the
absence of previous antifilarial treatment, Loa microfilar-
iae can spontaneously penetrate into the brain tissue,
where they may induce a cellular immunological reaction
[12,28]. Though difficult to demonstrate, one may con-
sider the possibility that the infiltrates and granulomas
which form around the parasites may then be resorbed
progressively, and that, even if the lesions are diffuse, this
may lead to a clinical improvement. Besides this, the sud-
den death of our patient, when the medical personnel was
providing care for his bedsores, constitutes also an
enigma. In the absence of autopsy, we can only propose
an hypothesis to explain this. One may consider the pos-
sibility of a cerebral embolism, which might have consti-
tuted a complication of the nephrotic syndrome, and/or
facilitated by the interruption of the anticoagulant treat-
ment. Lastly, such an embolism might also have been
facilitated by the very high microfilaraemia.
In conclusion, we have described the case of a patient who
presented a high infection with Loa loa and who devel-
oped, successively, two visceral manifestations which
could be caused by this infection. The imputability of Loa
loa in the clinical condition of our patient is questionable.
This is due to the fact that the spontaneous visceral com-
plications of loiasis are little known and that, in conse-
quence, the presence of a Loa infection is rarely examined
in patients presenting an encephalopathy or a glomeru-
lopathy. In the present case, the diagnosis of loiasis was
made only after three weeks of hospitalization. Besides
this, once the diagnosis of Loa infection had been made,
the investigations that would permit us to connect the
clinical picture and the filariasis are rarely made. This is
sometimes due to the cost of the required examinations
but we do think that two of them should be made on
patients who are infected with Loa loa and who present an
encephalopathy: an examination of the fundus, to see
whether there are typical retinal haemorrhages, and a
direct examination of centrifuged sample of CSF. In
patients with Loa infection and developing a glomerulop-
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